MSACL 2017 US
9th Annual Conference & Exhibits
Palm Springs, CA
January 22 - 26, 2017
The MSACL Conference provides a forum for discussion of developments in the clinical application of mass spectrometry. While immunoassay methods have dominated clinical analyses, mass spectrometric methods are now providing analytical results more rapidly and with less expense. MSACL brings together experts in the field with those driven to explore and understand clinical mass spectrometry, with the goal of facilitating mass spectrometry's adoption as a health care tool and accelerating the realization of improved patient care and reduced health care costs.
Scientific Program Tracks
The Scientific Program tracks focus on the following topic areas: Small Molecule Analysis, Proteomics, Metabolomics, Tissue Imaging and Microbiology.
Practical Training Track
In addition, MSACL also provides a track dedicated to Practical Training in clinical mass spectrometry. This track is intended to be a tutorial, with an emphasis on "how to" rather than the presentation of cutting-edge research. This track encourages active attendee interaction and participation to facilitate the learning process.
Travel Grant Program
MSACL's mission is educational and the organization provides several levels of Educational Travel Grants to support conference attendance:
It's the abstracts that make the meeting. Are you working in clinical mass spectrometry and have compelling results that you want to present at the most focused clinical mass spec meeting in the world? Submit your abstract for the MSACL Conference.
MSACL focuses on topics includingsmall molecule analysis, pain management, microbiology, chemistry/toxicology, proteomics, metabolomics, tissue imaging, and regulations and standards. A comprehensive list is below.
Abstract Submission Categories for MSACL 2017 US
*Note: Abstracts are solicited for the topics listed below, however, if no abstracts are submitted and accepted on any given topic then it will not be covered at the conference.
The target audience for this program includes pathologists, clinical laboratory directors and scientists, mass spectrometry and automated sample processing providers as well as laboratory diagnostic providers. This program will be beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.
This meeting will be critical to share emerging analytical information and work concerning regulations and standards. The goal of MSACL is to create an environment through which participants will be able to identify opportunities to develop the capacity to provide higher quality results, more rapidly and for lower overall cost, for patients within the healthcare system.